Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcus Biosciences Inc.

8.25
-0.0500-0.60%
Post-market: 8.250.00000.00%16:20 EDT
Volume:1.35M
Turnover:11.10M
Market Cap:873.15M
PE:-2.63
High:8.46
Open:8.29
Low:8.12
Close:8.30
Loading ...
Dec 12, 2019

Major Issues Report

Current report, item 5.02
Nov 25, 2019

Major Issues Report

[Amend] Current report, item 5.02
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 28, 2019

Major Issues Report

Current report, item 5.02
Sep 16, 2019

Major Issues Report

Current report, item 5.02
Sep 03, 2019

Major Issues Report

Current report, item 5.02
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Major Issues Report

Current report, item 5.07